In 2018, the global In Vitro Diagnostics (IVD) Products and Test market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global In Vitro Diagnostics (IVD) Products and Test status, future forecast, growth opportunity, key market and key players. The study objectives are to present the In Vitro Diagnostics (IVD) Products and Test development in United States, Europe and China.
- Table of Contents
- List of Tables & Figures
- Charts
- Research Methodology
Get FREE Sample of In Vitro Diagnostics (IVD) Products and Test Market Report
The key players covered in this study
- Abbott Laboratories(US)
- Becton Dickinson Company(US)
- bioMerieux SA(France)
- F. Hoffmann-La Roche Ltd.(Switzerland)
- Siemens Healthcare(Germany)
- Alere Inc(US)
- Beckman Coulter, Inc.(US)
- Bio-Rad Laboratories(US)
- Hologic(US)
- Ortho Clinical Diagnostics(US)
- Roche Diagnostics(US)
Market segment by Type, the product can be split into
- General Chemistries
- Critical Care
- Urinalysis
- Analyzers Blood Gases
- Workstations
- Others
Market segment by Application, split into
- Molecular Diagnostics
- Clinical Chemistry
- Diabetes and Glucose Testing
- Immunochemistry
- Hematology
- Others
Market segment by Regions/Countries, this report covers
- United States
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
The study objectives of this report are:
- To analyze global In Vitro Diagnostics (IVD) Products and Test status, future forecast, growth opportunity, key market and key players.
- To present the In Vitro Diagnostics (IVD) Products and Test development in United States, Europe and China.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of In Vitro Diagnostics (IVD) Products and Test are as follows:
- History Year: 2014-2018
- Base Year: 2018
- Estimated Year: 2019
- Forecast Year 2019 to 2025
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Email: [email protected]
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports
In vitro diagnostics are tests that can detect diseases, conditions, or infections.
Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.In Vitro Diagnostic (IVD) tests are a subset of medical devices.
In vitro diagnostic tests are used for in vitro examination of specimens derived from the human body to provide information for screening, diagnosis, or treatment monitoring purposes.Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-in-vitro-diagnostic-s-2019-2024-708According to this study, over the next five years the In Vitro Diagnostic (IVD) Products market will register a 6.8% CAGR in terms of revenue, the global market size will reach US$ 91480 million by 2024, from US$ 65820 million in 2019.
In particular, this report presents the global market share (sales and revenue) of key companies in In Vitro Diagnostic (IVD) Products business, shared in Chapter 3.This report presents a comprehensive overview, market shares, and growth opportunities of In Vitro Diagnostic (IVD) Products market by product type, application, key manufacturers and key regions and countries.This study considers the In Vitro Diagnostic (IVD) Products value and volume generated from the sales of the following segments:Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.Immuno DiagnosticsChemistry DiagnosticsMolecular DiagnosticsPOCTOtherSegmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.HospitalsLaboratoryOtherThis report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.AmericasUnited StatesCanadaMexicoBrazilAPACChinaJapanKoreaSoutheast AsiaIndiaAustraliaEuropeThe report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market.The key manufacturers covered in this report: Breakdown data in in Chapter 3.RocheAbbottDanaherSiemens HealthineersThermo Fisher ScientificSysmexBiomerieuxOrtho Clinical DiagnosticsBecton DickinsonBio-Rad LaboratoriesHologicJohnson and JohnsonQiagenMyriad GeneticsWondfoKHBDAAN GeneLeadman BiochemistryMindrayBioSinoIn addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole.
It also analyzes key emerging trends and their impact on present and future development.Research objectivesTo study and analyze the global In Vitro Diagnostic (IVD) Products consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.To understand the structure of In Vitro Diagnostic (IVD) Products market by identifying its various subsegments.Focuses on the key global In Vitro Diagnostic (IVD) Products manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.To analyze the In Vitro Diagnostic (IVD) Products with respect to individual growth trends, future prospects, and their contribution to the total market.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).To project the consumption of In Vitro Diagnostic (IVD) Products submarkets, with respect to key regions (along with their respective key countries).To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.To strategically profile the key players and comprehensively analyze their growth strategies.Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/global-in-vitro-diagnostic-s-2019-2024-708Table of content2019–2024 Global In Vitro Diagnostic (IVD) Products Consumption Market Report1 Scope of the Report1.1 Market Introduction1.2 Research Objectives1.3 Years Considered1.4 Market Research Methodology1.5 Economic Indicators1.6 Currency Considered2 Executive Summary2.1 World Market Overview2.1.1 Global In Vitro Diagnostic (IVD) Products Consumption 2014–20242.1.2 In Vitro Diagnostic (IVD) Products Consumption CAGR by Region2.2 In Vitro Diagnostic (IVD) Products Segment by Type2.2.1 Immuno Diagnostics2.2.2 Chemistry Diagnostics2.2.3 Molecular Diagnostics2.2.4 POCT2.2.5 Other2.3 In Vitro Diagnostic (IVD) Products Consumption by Type2.3.1 Global In Vitro Diagnostic (IVD) Products Consumption Market Share by Type (2014–2019)2.3.2 Global In Vitro Diagnostic (IVD) Products Revenue and Market Share by Type (2014–2019)2.3.3 Global In Vitro Diagnostic (IVD) Products Sale Price by Type (2014–2019)2.4 In Vitro Diagnostic (IVD) Products Segment by Application2.4.1 Hospitals2.4.2 Laboratory2.4.3 Other2.5 In Vitro Diagnostic (IVD) Products Consumption by Application2.5.1 Global In Vitro Diagnostic (IVD) Products Consumption Market Share by Application (2014–2019)CONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170 / +91 8087042414Email: [email protected] Us On linkedin :- https://www.linkedin.com/company/grand-research-store/
In-Vitro Diagnostics Industry Research Report, By Product & Services (Reagents & Kits, Instruments, Data management software), By Applications (Infectious Diseases,Non-infectious diseases), By End User– Global Forecast Till 2023In vitro diagnostics (IVD) are medical devices used for conducting medical testing of samples taken out of the human or animal body such as blood, urine and tissue.
In its recently published analysis, MRFR also asserts that the market would register a double digit CAGR by the end of assessment period of 2023.Extensive demand for IVD owing to growing demand, ease of use and growing healthcare diagnostic use is a key driving force behind the market.IVD comprises a large and important segment of the healthcare sector and is experiencing rapid spurts of growth owing to technological advancements, greater satisfaction owing to better detection and accuracy, growing demand for treatment monitoring, and explosive availability of over the counter IVD kits.However, the restrictive legal framework in nations like Germany favouring the generic, IUD products and the shift to sensor-based products is constraining the market growth.
The centralized public procurement in many countries is reducing market competition and increasing uncertainty in the industry.Major Players:Players leading the global IVD market include Danaher Corporation, Thermo Fisher Scientific, Grifols S.A, Ortho Clinical Diagnostics, Abbott Laboratories, Qiagen N.V., Sysmex Corporation, BioMérieux S.A, DiaSorin S.p.A, F. Hoffmann-La Roche AG, Siemens AG, Bio-Rad Laboratories Inc., Becton Dickinson and Company, among others.Global In-Vitro Diagnostics (IVD) Market – SegmentsThe report is segmented into three dynamics to widen the scope of understanding,By Product & Services : Reagents & Kits, Instruments, Data Management Software among others.By Technology : Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology among others.By Application : Infectious Diseases, Non-Infectious Diseases among others.By End-use : Hospitals, Laboratories, Academic Institutes among others.By Regions : North America, Europe, Asia Pacific, and the Rest-of-the-World.Browse More Information @ https://www.marketresearchfuture.com/reports/in-vitro-diagnostics-market-1165 Global In-Vitro Diagnostics (IVD) Market – Regional AnalysisNorth America dominates the global IVD market owing to factors such as excellent reimbursement, large healthcare expenditure and compulsory screening regulations.The IVD market in Europe is growing owing to large medical device industry and growing healthcare expenditure.
However, the European market is exhibiting low CAGR growth owing to saturation of the market and the falling price of IUD products.
Germany followed by Italy, France, Spain and the U.K. accounted for the largest markets in Europe.The Asia Pacific IVD market is expected to emerge as the largest market owing to large population.
China, Japan and India are expected to dominate the Asia Pacific market owing to growing economy and manufacturing activities.
At an estimated value of over USD 72.02 billion in 2019, the Global In Vitro Diagnostics (IVD) Market is predicted to thrive at a CAGR of 4.1% and valued at over USD 112.05 billion over the forecast year 2020-2030.In vitro diagnostics (IVD) are the tests for detecting disease and infections.
It is done on samples such as tissue or blood taken from the human body.
The in vitro diagnostics is experiencing a significant popularity in healthcare sector due to its efficacy in diagnosing numerous medical conditions such as infectious diseases, cardiac disorders, cancer, and nephrological disorders.Access Full Description of this report at:- https://www.nextmsc.com/report/in-vitro-diagnostics-ivd-market Top Companies: Abbott Laboratories, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, BioMérieux SA, Sysmex Corporation, Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche AG, Siemens AG, QIAGEN N.V., Thermo Fisher Scientific, Inc and others.The global In vitro diagnostics (IVD) market share is segmented on the basis of product & service, technique, application, end user, and geography.
As per the application, the market is divided into infectious diseases, cancer, immune system disorders, cardiac diseases, nephrological diseases, gastrointestinal diseases, and others.
On the basis of end user, the market is segmented into standalone laboratory, academic & medical schools, hospitals, point of care, and others.
Geographic fragmentation and analysis of each segment includes regions comprising North America, Europe, Asia Pacific and RoW.Request sample copy of this report at:- https://www.nextmsc.com/in-vitro-diagnostics-ivd-market/request-sample In terms of geography, North America held major share of the market in 2019.
The global In Vitro Diagnostics (IVD) Quality Control Market is anticipated to reach USD 1.13 billion by 2024.
The rising number of certified clinical laboratories requires quality control (QC) services to maintain their standards, associated with the increasing acceptance of third party providers of quality control services, to ensure the accurate and reproducible test results, and better outcomes which is anticipated to drive the growth.For the establishment of definite standards of quality, the internal Quality Control (QC) programs and the external QAS (Quality Assurance Schemes) is very important to ensure validity and reliability of the test results obtained by the IVD devices.
These programs are essential in confirming the delivery of patient diagnostic outcomes, which are reliable and without errors, such as misdiagnosis because of device-related errors, which can impact the health of the patient.Download Free Sample Report @ https://www.millioninsights.com/industry-reports/in-vitro-diagnostics-ivd-quality-control-market/request-sampleThe regulation of these In vitro diagnostics devices are controlled by the respective regulatory bodies, which includes the U.S. FDA (Food and Drug Administration), the International Medical Device Regulators Forum (IMDRF), the European Commission, the Australian Therapeutic Goods Administration (TGA), the Eurasian Economic Union (EEU) and the Brazilian National Health Surveillance Agency (ANVISA).The currently undergoing, extensive R related activities beside the introduction of new laws with the aim of improving the efficacy and safety levels of the IVD services are anticipated to drive market growth.
For example, in September 2012, a new regulation for IVD devices was published by the European Commission targeted to enhance the transparency, safety and the traceability without constraining innovation.
The QC schemes are appropriate to plasma-based, whole blood-based and serum-based products.
In 2016, QC market was one of the largest segments because of the rapidly developing IVD technologies and the existence of numerous internal QC programs for the different features of the IVD device-based procedures of testingApplication InsightsThere are numerous applications of the IVDs, which includes haematology, immunology, coagulation, clinical chemistry, molecular diagnostics and microbiology.